Israel Manzanedo

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 19, 2025
Role of surgery in metastatic gastric cancer.

Israel Manzanedo, Ángel Serrano, Estíbalitz Pérez-Viejo

|Jun 10, 2023
Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP).

Israel Manzanedo, Fernando Pereira, Pedro Cascales-Campos

|Mar 29, 2023
Peritoneal Mesothelioma in a High Volume Peritoneal Surface Malignancies Unit.

Fernando Pereira, Mónica Pereira, Israel Manzanedo

|Mar 29, 2023
Gastric Cancer with Peritoneal Metastases: Current Status and Prospects for Treatment.

Israel Manzanedo, Fernando Pereira, Estíbalitz Pérez-Viejo

|Feb 22, 2019
The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study.

I Manzanedo, F Pereira, Á Serrano

Pageof 1

Frequent Collaborators

3 joint publications

Fernando Pereira

1 joint publications

Estíbalitz Pérez-Viejo

1 joint publications

Enrique Asensio

1 joint publications

Beatriz Martínez-Torres